Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
5(71%)
Results Posted
50%(1 trials)

Phase Distribution

Ph phase_2
1
14%
Ph phase_1
5
71%
Ph phase_3
1
14%

Phase Distribution

5

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
5(71.4%)
Phase 2Efficacy & side effects
1(14.3%)
Phase 3Large-scale testing
1(14.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

5

trials recruiting

Total Trials

7

all time

Status Distribution
Active(5)
Completed(2)

Detailed Status

Recruiting3
Completed2
Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials
7
Active
5
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 15 (71.4%)
Phase 21 (14.3%)
Phase 31 (14.3%)

Trials by Status

completed229%
recruiting343%
active_not_recruiting229%

Recent Activity

5 active trials
Showing 5 of 7
recruitingphase_1

Evaluate the Effect of Vimseltinib on P-glycoprotein (P-gp) Inhibition in Healthy Male Participants

NCT07744802
recruitingphase_1

Evaluate the Effect of Vimseltinib on Pharmacokinetics of Combined Oral Contraceptive (Ethinyl Estradiol/Levonorgestrel)

NCT07539090
active_not_recruitingphase_1

Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor

NCT03069469
active_not_recruitingphase_3

Study of Vimseltinib for Tenosynovial Giant Cell Tumor

NCT05059262
completedphase_1

Evaluate the Effect of Vimseltinib on Organic Cation Transporter 2 (OCT2)

NCT07158411
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT07744802Phase 1

Evaluate the Effect of Vimseltinib on P-glycoprotein (P-gp) Inhibition in Healthy Male Participants

Recruiting
NCT07539090Phase 1

Evaluate the Effect of Vimseltinib on Pharmacokinetics of Combined Oral Contraceptive (Ethinyl Estradiol/Levonorgestrel)

Recruiting
NCT03069469Phase 1

Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor

Active Not Recruiting
NCT05059262Phase 3

Study of Vimseltinib for Tenosynovial Giant Cell Tumor

Active Not Recruiting
NCT07158411Phase 1

Evaluate the Effect of Vimseltinib on Organic Cation Transporter 2 (OCT2)

Completed
NCT07158398Phase 1

Evaluate the Effect of Vimseltinib on the Pharmacokinetics of a BCRP and OATP1B1 Substrate

Completed
NCT06619561Phase 2

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

Recruiting

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7